{
    "Trade/Device Name(s)": [
        "Verigene System",
        "Verigene Clostridium difficile Nucleic Acid Test (CDF)"
    ],
    "Submitter Information": "Nanosphere, Inc.",
    "510(k) Number": "K123197",
    "Predicate Device Reference 510(k) Number(s)": [
        "K113358",
        "K110203",
        "K092566"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OZN"
    ],
    "Summary Letter Date": "October 10, 2012",
    "Summary Letter Received Date": "October 11, 2012",
    "Submission Date": "November 27, 2012",
    "Regulation Number(s)": [
        "21 CFR 866.3130"
    ],
    "Regulation Name(s)": [
        "C. Difficile Nucleic Acid Amplification Test Assay"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "genetic molecular"
    ],
    "Analyte(s)": [
        "Clostridium difficile toxin A (tcdA) gene",
        "Clostridium difficile toxin B (tcdB) gene",
        "Clostridium difficile tcdC gene",
        "Clostridium difficile binary toxin (cdt) gene",
        "single base pair deletion at nucleotide 117 in tcdC"
    ],
    "Specimen Type(s)": [
        "Unformed stool",
        "Liquid stool",
        "Soft stool"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Verigene System",
        "Verigene Reader",
        "Verigene Processor SP"
    ],
    "Method(s)/Technology(ies)": [
        "Polymerase chain reaction (PCR)",
        "Nanoparticle-based array hybridization assay",
        "Automated nucleic acid extraction",
        "Microarray detection",
        "Magnetic bead-based DNA isolation",
        "Gold nanoparticle probe-based endpoint detection"
    ],
    "Methodologies": [
        "Molecular diagnostics",
        "Multiplexed nucleic acid amplification",
        "Hybridization",
        "Microarray analysis"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay",
        "System",
        "Analyzer",
        "Instrument",
        "Cartridge",
        "Consumable"
    ],
    "Document Summary": "FDA 510(k) summary for Verigene Clostridium difficile Nucleic Acid Test (CDF), a multiplexed PCR and nanoparticle-based hybridization assay for rapid detection of toxigenic C. difficile DNA in stool on the Verigene System.",
    "Indications for Use Summary": "Qualitative multiplexed in vitro diagnostic test on the Verigene System for rapid detection of toxin A (tcdA), toxin B (tcdB), and tcdC gene sequences of toxigenic Clostridium difficile and presumptive identification of PCR ribotype 027 strains from unformed stool, as an aid in diagnosing C. difficile infection; detection of ribotype 027 is for epidemiological purposes only.",
    "fda_folder": "Microbiology"
}